| original | translation |
|----------|-------------|
| This has been bugging me for years now, and I thought one of you fine people would know - in Eclipse's .classpath files, what is the combineaccessrules attribute of the classpathentry element actually used for?<br/><br/>I can see in the Java Build Path config dialog that it can be maniuplated, but I can't think of a good use case for it. If I muck about with the settings, or modify the .classpath file manually, it doesn't seem to have any effect.<br/><br/>I'm hoping someone else has put it to good use, and I can steal their ideas. Basically, it's an itch I'm trying to scratch.<br/><br/>3 Answers<br/><br/>With proper use of access rules you can prevent using "internal" and/or "non-api" classes and methods. When you add a class or package as Forbidden or Discouraged the compiler show an error or warning when you use that class or class from the specified package. For a longer introduction of access rules you should read this short article.<br/><br/>For using combine access rules imagine the following situation:<br/><br/>You have 2 projects, A and B.<br/><br/>On the classpath of project A there is a jar file that is exported. The jar contains some "stable api", "unstable api" and "non-api" public classes.<br/><br/>Project B depends on project A.<br/><br/>You do not allow using "non-api" classes in project A so you set some Forbidden access rules on those classes / packages.<br/><br/>In project B you do not allow using "non-api" as well, but you do want to get a warning when using "unstable api". In this case in project B you only have to set the additional Discouraged access rules if you check the Combine rules with the access rules of the exported project entries.<br/><br/>Access rules are handy little things, but dangerous. They exclude a source file from the project compiler but leave the file intact in the filesystem.<br/><br/>The project I work on has a bootstrap class in one of our source folders, but if we include the entire folder the project classpath it won't compile (it's a long story and the build process handles this).<br/><br/>So we use an eclipse access rule to exclude it and it never bothers us during development. This means we can't easily change the code, but it's one of those classes that literally hasn't been touched in years.<br/><br/>Combine Access Rules, judging by the JavaDoc, is a real edge use case. To use it you would have to have:<br/><br/>an access rule in an exported source entry of one project<br/><br/>a link to that project from a parent project<br/><br/>a need to combine the access rules of the sub project with the parent<br/><br/>I really can't say how it would be useful, but I hope that at least answers your "what is it" question :) | Dan ġie bugging lili għas-snin issa, u ħsibt dwar wieħed mill-persuni fin-negozju kien jaf - fil-fajls tal-klaxxjatura ta' Eclips, x'inhu l-attributi ta' l-ackles ta' l-element classpathy attwalment użati għal?<br/><br/>Kapaċi nara fid-djalogu tal-Java Build li tista' tiġi manipulata, imma ma nistax naħseb f'każ ta' użu tajjeb għalih. Jekk niġbed fuq is-settings, jew inimmodifika l-fajl.classpath manwalment, ma jidhirx li għandi xi effett.<br/><br/>Jien bit-tama ta'xi ħadd ieħor tpoġġih f'użu tajjeb, u nista' niskoraġġixxi l-ideat tagħhom.Baċilment, huwa xi ħaġa li qed nipprova nxandar.<br/><br/>3 It-tweġibiet<br/><br/>Bl-użu xieraq ta' regoli ta' aċċess tista' tevita l-użu ta' klassijiet u metodi "intalati" u/jew "mhux api". Meta żżid klassi jew pakkett bħala Probidjenti jew Imkuraġġita l-comiler juri żball jew twissija meta tuża dik il-klassi jew klassi mill-pakkett speċifikat. Għal introduzzjoni itwal ta' regoli ta' aċċess għandek taqra dan l-artikolu qasir.<br/><br/>Għall-użu ta' regoli ta' aċċess li jikkombinaw is-sitwazzjoni li ġejja:<br/><br/>Għandek 2 proġetti, A u B.<br/><br/>Fuq il-klassika tal-proġett A hemm fajl vażett li huwa esportat.Il-vażett fih xi klassijiet pubbliċi " stabbli api", "mhux stabbli api" u "mhux api".<br/><br/>Proġett B jiddependi fuq il-proġett A.<br/><br/>Inti ma jippermettux l-użu ta' klassijiet "mhux api" fil-proġett A sabiex inti tistabbilixxi xi regoli ta' aċċess pprojbit fuq dawk il-klassijiet / pakketti.<br/><br/>Fil-proġett B inti ma jippermettux li jużaw "mhux api" kif ukoll, iżda inti tixtieq li tikseb twissija meta tuża "appi instabbli". F'dan il-każ fil-proġett B inti għandek biss biex jistabbilixxu r-regoli addizzjonali dwar l-aċċess Imħarbat jekk inti tiċċekkja r-regoli tal-kombinazzjoni mar-regoli tal-aċċess tal-entrati tal-proġett esportati.<br/><br/>Ir-regoli ta' aċċess huma affarijiet ftit utli, iżda perikolużi. Huma jeskludu fajl sors mill-compiler tal-proġett imma jħallu l-fajl intatt fil-fajl.<br/><br/>Il-proġett naħdem fuq il-klassi bootstrap f'wieħed mill-folders tas-sors tagħna, iżda jekk aħna jinkludu l-fowlder kollu tal-klassi tal-proġett li mhux se jikkompilaw (huwa storja twila u l-proċess tal-bini jittratta dan).<br/><br/>Għalhekk nużaw regola tal-aċċess għall-kopji biex nagħlquha u qatt ma nagħżilna n-nies matul l-iżvilupp.Dan ifisser li ma nistgħux inbiddlu faċilment il-kodiċi, iżda wieħed minn dawk il-klassijiet li litteralment ma ġiex immess fi snin.<br/><br/>Għaqqad ir-Regoli ta' Aċċess, li tiġġudika l-JavaDoc, huwa każ reali ta' użu tax-xifer. Biex tużaha trid:<br/><br/>regola tal-aċċess f'sors esportat tad-dħul ta' proġett wieħed<br/><br/>link għal dak il-proġett minn proġett prinċipali<br/><br/>ħtieġa li jiġu kkombinati r-regoli ta' aċċess tas-suġġett tal-proġett mal-ġenitur<br/><br/>I verament ma tistax tgħid kif ikun utli, imma nittama li mill-inqas tirrispondi l-mistoqsija tiegħek "dak li huwa":) |
| Clues to heart disease in unexpected places, researchers discover<br/><br/>A major factor in the advance of heart disease is the death of heart tissue, a process that a team of scientists at Temple University School of Medicine's (TUSM) Center for Translational Medicine think could be prevented with new medicines. Now, the researchers are one step closer to achieving that goal, thanks to their discovery of a key molecule in an unexpected place in heart cells – mitochondria, tiny energy factories that house the controls capable of setting off cells' self-destruct sequence.<br/><br/>The study is the first to identify the molecule, an enzyme known as GRK2 (G protein-coupled receptor kinase 2), in mitochondria. It was led by Walter J. Koch, Ph.D., Professor and Chairman of the Department of Pharmacology at TUSM, and Director of the Center for Translational Medicine at TUSM.<br/><br/>"We have known that GRK2 is involved in the pathological development of certain heart diseases, such as chronic heart failure, and that its increased activity can lead to the death of heart cells. But its mechanism for the latter was unclear," Koch said. In addition, while the enzyme was known to be present in elevated levels in the hearts of patients with heart failure, the reasons for its rise were not fully understood.<br/><br/>Normally, GRK2 hangs out near the plasma membrane of heart cells, where it turns off certain signals transferred from the blood to the tissue. But the researchers at Temple found that it moves to mitochondria in response to two classic features of heart disease, ischemic insult and ensuing oxidative stress. These two processes, in which a momentary lapse in the delivery of oxygen-rich blood to diseased tissues causes a sudden increase in damaging reactive molecules, converge to stimulate the self-destruct program of heart cells. They ultimately cause whole sections of heart tissue to die, leaving behind scars that can severely compromise the ability of the heart to function properly.<br/><br/>Koch's team found that in ischemic heart cells the movement of GRK2 from the cell membrane to mitochondria is chaperoned by a substance called heat-shock protein 90 (Hsp90), which is produced in cells in response to stress. By blocking Hsp90's ability to bind to GRK2, the researchers were able to prevent the enzyme's delivery to mitochondria.<br/><br/>They reached the same result after mutating a residue called Ser670 in the tail end of GRK2's amino acid structure. When the Ser670 residue is activated by a chemical signal, Hsp90 is nudged into action, attaching to GRK2 and carrying it to mitochondria. Mutation of Ser670 also resulted in a wholesale reduction in pro-death signaling in affected heart cells. The effects were observed in human heart muscle cells grown in the laboratory and in mice that had experienced induced heart attacks. The results are detailed in the April 12 issue of the journal Circulation Research.<br/><br/>Koch explained that the translation of the new findings to the clinic, where they would benefit patients, lies in developing new therapeutic approaches that are capable of limiting both the activity of GRK2 and its ability to associate with mitochondria.<br/><br/>"We have a great opportunity here to develop new medicines against heart failure and improve upon this significant disease syndrome," he said. He added that this will take some time but that molecular and pharmacological strategies against GRK2 are in the works. "We are developing a gene therapy tool known as the ßARKct, which is a peptide inhibitor of GRK2, and are quite excited about a clinical trial."<br/><br/>Koch and his team have shown in pre-clinical studies that delivery of the ßARKct to failing hearts can inhibit GRK2 and thereby protect the heart from death. In the new study, ßARKct was found to block the enzyme's transit to mitochondria after ischemia, an important step now believed to contribute to the peptide's beneficial effects in heart failure.<br/><br/>There is much yet to learn about GRK2, however, according to Koch. "We still need to find out exactly what GRK2 is doing in the mitochondria," he said. "We need to figure out what it interacts with and specifically regulates."<br/><br/>What the team uncovers could solidify GRK2 as a key target for therapeutic strategies against heart disease.<br/><br/>Related Stories<br/><br/>Inhibition of a protein known to contribute to heart failure also appears to be protective of the heart in more acute cardiac stress injury, namely ischemia reperfusion, according to two studies conducted at the Center for Iowa researchers have previously shown that an enzyme called CaM kinase II plays a pivotal role in the death of heart cells following a heart attack or other conditions that damage or stress heart muscle. Loss | Fajls għall-mard tal-qalb f'postijiet mhux mistennija, ir-riċerkaturi jiskopru<br/><br/>Fattur ewlieni bil-quddiem tal-mard tal-qalb huwa l-mewt tat-tessut tal-qalb, proċess li tim ta' xjentisti fl-Iskola tal-Mediċina tat-Tempju tal-Università (TUSM) Ċentru għall-mediċina traduzzjoni taħseb li jista' ma' mediċini ġodda. Issa, ir-riċerkaturi huma pass wieħed eqreb lejn il-kisba ta' dan l-għan, bis-saħħa tal-iskoperta tagħhom ta' molekula ewlenija f'post mhux mistenni f'ċelluli tal-qalb – mitochondria, fabbriki tal-enerġija żgħar li jgħixu l-kontrolli kapaċi li jistabbilixxu sekwenza awto-qerda taċ-ċelloli.<br/><br/>L-istudju huwa l-ewwel li jidentifikaw il-molekula, enzima magħrufa bħala GRK2 (KĠ kuplikata ta' proteini), fil-mikokondrija. Dan ġie mmexxi minn Walter J. Koch, Ph.D., Professur u President tad-Dipartiment tal-Farmakoloġija f'TUSM, u Direttur taċ-Ċentru għall-mediċina tat-traduzzjoni f'TUSM.<br/><br/>Aħna nafu li GRK2 huwa involut fl-iżvilupp patoloġiku ta' ċertu mard tal-qalb, bħal falliment tal-qalb kronika, u li l-attività miżjuda tiegħu tista' twassal għall-mewt taċ-ċelluli tal-qalb. Iżda l-mekkaniżmu tiegħu għal dawn tal-aħħar ma kienx ċar," qal Koch. Barra minn hekk, filwaqt li l-enzima kienet magħrufa bħala preżenti fil-livelli elevati fil-qlub tal-pazjenti b'falliment tal-qalb, ir-raġunijiet għaż-żieda tagħha ma kinux mifhuma kompletament.<br/><br/>Normalment, GRK2 hangs barra ħdejn il-membrana tal-plażma taċ-ċelloli tal-qalb, fejn titfi ċerti sinjali trasferiti mid-demm għat-tessut. Iżda r-riċerkaturi f'Tempju sabu li jiċċaqlaq għal mitochondria b'rispons għal żewġ karatteristiċi klassiċi ta' mard tal-qalb, insult iskemiku u stress ossidattiv li jirriżulta. Dawn iż-żewġ proċessi, li fihom jiskadi l-mument fit-twassil tad-demm tal-ossiġenu għat-tessuti tal-mard jikkawża żieda f'daqqa fil-molekuli reattivi, jikkonverġu biex jistimulaw il-programm awto-qerda taċ-ċelloli tal-qalb. Fl-aħħar mill-aħħar huma jikkawżaw sezzjonijiet sħaħ tat-tessut tal-qalb li jmutu, li jħallu wara skars li jistgħu jikkompromettu b'mod sever il-kapaċità tal-qalb li tiffunzjona tajjeb.<br/><br/>It-tim ta' Koch sabet li fiċ-ċelloli tal-qalb iskimiċi il-moviment tal-GRK2 mill-membrana taċ-ċellula għal mitochondria huwa mgħammrin minn sustanza msejħa hot-xokk proteina 90 (Hsp90), li hija prodotta fiċ-ċelloli b'reazzjoni għall-istress. Billi jibblokka l-kapaċità ta' Hsp90 li jorbtu lill-GRK2, ir-riċerkaturi kienu kapaċi jimpedixxu l-kunsinna tal-enzima lill-mitochondria.<br/><br/>Huma laħqu l-istess riżultat wara li ħallsu residwu imsejjaħ Ser670 fl-aħħar tad-denb ta' l-istruttura ta' l-aċidu amino GRK2.Meta r-residwu ta' l-Ser670 jiġi attivat b'sinjal kimiku, Hsp90 huwa mnissla fl-azzjoni, mehmuża mal-GRK2 u li jġorrha lejn il-mitochondria. mutazzjoni ta' Ser670 wasslet ukoll għal tnaqqis fil-pro-mewt f'ċelloli tal-qalb affettwati. L-effetti ġew osservati fiċ-ċelloli tal-muskoli tal-qalb umani mkabbra fil-laboratorju u fil-ġrieden li kienu esperjenzaw attakki tal-qalb. Ir-riżultati huma ddettaljati fil-ħarġa ta' April 12 tar-Riċerka taċ-Ċirkolazzjoni tal-Ġurnal.<br/><br/>Koch spjega li t-traduzzjoni tas-sejbiet il-ġodda għall-klinika, fejn huma jkunu ta' benefiċċju għall-pazjenti, tinsab fl-iżvilupp ta' approċċi terapewtiċi ġodda li huma kapaċi jillimitaw kemm l-attività tal-GRK2 kif ukoll il-kapaċità tagħha li tkun assoċjata mal-mitochondria.<br/><br/>Aħna għandna opportunità kbira hawn biex jiżviluppaw mediċini ġodda kontra l-falliment tal-qalb u jtejbu fuq din is-sindrome sinifikanti tal-marda," qal. Żied jgħid li dan se jieħu ftit ħin iżda li l-istrateġiji molekulari u farmakoloġiċi kontra l-GRK2 qegħdin fix-xogħlijiet. Aħna qegħdin jiżviluppaw għodda ta' terapija tal-ġeni magħrufa bħala l-"GRKact, li hija inibitur tal-peptidi tal-GRK2, u huma pjuttost eċitat dwar prova klinika."<br/><br/>Koch u t-tim tiegħu wrew fl-istudji pre-kliniċi li l-konsenja tal-ßARKt lill-qlub tan-nuqqas jistgħu jimpedixxu GRK2 u b'hekk jipproteġu l-qalb mill-mewt. Fl-istudju l-ġdid, ßARKt kien instab li blokk it-tranżitu tal-enzima għal mitochondria wara l-ischemija, pass importanti issa kien maħsub biex jikkontribwixxi għall-effetti benefiċi tal-peptidi fil-falliment tal-qalb.<br/><br/>Iżda għadna nitgħallmu dwar il-GRK2, madankollu, skont Koch. "Naħsilhom bżonn issir taf eżattament x'qed jagħmel il-GRK2 fil-mitochondria," qal. "Jeħtieġ li nidċifraw dak li jinteraġixxi ma' u tirregola b'mod speċifiku."<br/><br/>Dak li t-tim ma jikxef jista' jissoda l-GRK2 bħala mira ewlenija għall-istrateġiji terapewtiċi kontra l-mard tal-qalb.<br/><br/>Stejjer Relatati<br/><br/>L-inibizzjoni ta' proteina magħrufa li tikkontribwixxi għall-falliment tal-qalb tidher ukoll bħala protezzjoni tal-qalb f'dannu ta' stress kardijaku aktar akut, jiġifieri r-riperfużjoni tal-Iskema, skont żewġ studji mwettqa fiċ-Ċentru għar-riċerkaturi ta' Iowa, urew li enzima msejħa kuġina II għandha rwol kruċjali fil-mewt ta' ċelluli tal-qalb wara attakk tal-qalb jew kundizzjonijiet oħra li jagħmlu ħsara jew li għandhom muskolu tal-qalb. Telf ta' kreditu |
| Slide 1: ==== ==== How To Cure Angular Cheilitis -- Success Guaranteed -- CLICK BELOW  ==== ====<br/>Angular cheilitis is an inflammatory lesion at the corner of the mouth and often occurs bilaterally. It is often characterized by cracks or deep fissures. In severe cases, the cracks may bleed when the mouth is opened and shallow ulcers or a crust may form. Although the sores of angular cheilitis may later become infected by the fungus Candida albicans or other pathogens, studies have linked the onset of angular cheilitis with nutritional deficiencies, particularly riboflavin (vitamin B 2) and iron deficiency, which in turn may be indicative of a poor diet or malnutrition. Zinc deficiency has also been associated with angular cheilitis. Other causes can be: the papilloma virus, stress, antibiotics, allergic substances and sunburn. How to treat angular cheilitis naturally at home:<br/>Keep your lips moisturized at all times: you can do that by applying unflavored lip balm or gloss or an aloe Vera gel. You can also use several natural home remedies, such as: Vitamin E: buy Vitamin E capsules and break them with a sterilized needle. Then apply the Vitamin E oil to the affected areas to treat cheilitis. Cucumber: just cut a piece of cucumber and rub it on your mouth. Neem leaf: rub neem leaf distill on the afflicted areas. Olive oil: Rub some olive oil over your lips. Honey: apply honey on your lips and wash it off after at least 15 minutes. Honey has excellent antibacterial properties and can help the healing process. Eat better and healthier: the best way to prevent and treat cheilitis is to nourish your body from the inside. Try to eat foods that are rich in vitamin B (brewer's yeast, legumes, fish, potatoes, peanuts, eggs, poultry, liver, meat, milk, brown rice, soybeans, butter and whole grain cereals) and iron (liver, oysters, pumpkin seeds, spinach, prunes, artichokes, canned beans, sardines and shrimps). An easy way to get all the vitamins you need for an effective angular cheilitis treatment is to take Vitamin B12 and Vitamin B1 supplements to boost your immune system and help your body fight off the bacteria and eliminate the disease. Avoid drinking orange juice: Orange juice is very acidic and can irritate the delicate skin at the corners of your mouth and also cause a lot of pain. If you really want to drink some orange juice, you can just use a straw. There are also other foods that can create irritation, such as spicy foods, lemonade and citrus fruits in general, so stay away from these foods, if you don't want to make this condition worse.<br/>Next find out the #1 method to Treat Angular Cheilitis Naturally! Just Click here to find out how!<br/>Slide 2: Article Source: <br/>==== ==== How To Cure Angular Cheilitis -- Success Guaranteed -- CLICK BELOW  ==== ==== | Żerriegħa 1: ========= Kif tikkura angolari Cheilitis -- Suċċess garantita - KLACK BELOW =====<br/>Ċilit angolari huwa leżjoni infjammatorji fil-kantuniera tal-ħalq u ħafna drabi tiġri bilateralment. Ħafna drabi huwa kkaratterizzat minn xquq jew xquq fondi.F'każijiet severi, il-xquq jistgħu jittaqqlu meta tinfetaħ il-ħalq u għandhom forma ta' u juru lulċeri jew qoxra. Għalkemm is-sores tal-kimiċi angolari jistgħu aktar tard jiġu infettati mill-fungus Kandida albicans jew patoġeni oħra, l-istudji għandhom rabta mal-bidu tal-kimiċi angolari bin-nuqqasijiet nutrizzjonali, b'mod partikolari riboflavin (vitamina B 2) u nuqqas tal-ħadid, li min-naħa tagħhom jistgħu jiġu indikattivi ta' dieta ħażina jew malnutrizzjoni. In-nuqqas ta' żingu kien assoċjat ukoll mal-kimiċi angolari. Kawżi oħra jistgħu jkunu: il-virus tal-papilloma, l-istress, l-antibijotiċi, is-sustanzi allerġiċi u x-xemx.<br/>Żomm ix-xufftejn tiegħek moisturized f'kull ħin: tista 'tagħmel li billi tapplika ballun tal-lip jew tleqqija mhux togħma jew ġel tal-era aloe. Tista 'tuża wkoll diversi rimedji naturali fid-dar, bħal: Vitamina E: jixtru kapsuli vitamina E u kisser b'labra sterilizzata. Imbagħad applika ż-żejt tal-vitamina E għaż-żoni milquta biex jittrattaw il-cheilite.Cucumber: biss maqtugħa biċċa tal-cucumber u rokx fuq ħalqek.Neem weraq: gomma nem weraq distillat fuq iż-żoni milquta. Żejt taż-żebbuġa: Rub xi żejt taż-żebbuġa fuq ix-xufftejn tiegħek. Għasel: japplikaw għasel fuq ix-xufftejn tiegħek u aħsel off wara mill-inqas 15-il minuta. Għasel għandha proprjetajiet antibatteriċi eċċellenti u jistgħu jgħinu l-proċess tal-fejqan. Tiekol aħjar u aktar b'saħħitha: l-aħjar mod biex jipprevjenu u jikkura l-cheilitis huwa li nutriti ġisem tiegħek mill-ġewwa. Ipprova l-ikel li huwa rikk fil-vitamina B (butir, legumi, ħut, patata, bajd, tjur, fwied, ħalib, ross kannella, soya, butir u qamħ sħiħ taċ-ċereali) u ħadid (fwied, soybean, żerriegħa tal-qargħa ħamra, spanjol, prunes, ħwawar bl-arti, fażola tal-bott, sardina u gambli). Mod faċli biex tikseb il-vitamini kollha li għandek bżonn għal trattament cheilite angolari effettiva huwa li jieħdu supplimenti vitamina B12 u vitamina B1 biex is-sistema immuni tiegħek u tgħin ġismek ġlieda barra l-batterja u telimina l-marda. Jevitaw meraq oranġjo tax-xorb: meraq oranġjo hija ħafna aċidużi u jistgħu irritata l-ġilda delikat fil-kantunieri tal-ħalq tiegħek u wkoll jikkawżaw ħafna uġigħ.Jekk verament tixtieq tixrob meraq oranġjo, inti tista biss tuża tiben. Hemm ukoll ikel ieħor li jista' joħloq irritazzjoni, bħal ikel b'riha tfuh, lumiade u frott taċ-ċitru b'mod ġenerali, sabiex jibqgħu ‘l bogħod minn dawn l-ikel, jekk ma tridx tagħmel din il-kondizzjoni agħar.<br/>Li jmiss sib il-metodu #1 biex jittrattaw Angolari Cheilitis Naturalment! Eżatt Ikklikkja hawn biex issir taf kif!<br/>Slide 2: sors ta' l-Artikolu:<br/>========== Kif tikkura Angolari Cheilitis - Suċċess garantita - KLACK BELOW ==== |
| Kind Hearts And Cauliflowers<br/><br/>It sort of chokes you up when you think of the beautiful friendship between Jake Mintz and his boy, Wilf Greaves<br/><br/>Yet when Greaves retired last year and went to work on the Detroit docks, boxing men familiar with Jake Mintz's genius had not the slightest doubt that, had Jake lived on, he somehow would have finagled a shot at the world title for Wilf. Somehow he would have sneaked him beyond the edge. And who knows? Wilf might have met a champion on an off night and won the title. | It-tip ta' qlub u l-Cauilflowers<br/><br/>Huwa xorta ta' chokes inti up meta taħseb ta'ħbiberija sabiħa bejn Jake Mintz u boy tiegħu, Milf Graves<br/><br/>Imma meta Graves irtira s-sena l-oħra u mar jaħdem fuq il-baċiri tad-Detroit, il-familja tal-boxing mal-ġenju ta' Jake Mintz ma kinitx l-iċken dubju li, Jake għexu, b'xi mod kien se tkun sabet sparatura fit-titlu tad-dinja għall-Wilf. B'xi mod kien ikun imkeċċi lil hinn mit-tarf, u lil min jaf? Tul il-ħajja seta' kien li ltaqa' ma' kampjonat bil-lejl u rebaħ it-titlu. |
| Featured ResearchShare ThisIntensive care patients are especially vulnerable to picking up infections in hospital, due to their poor health. Researchers from the Karolinska Institutet in Sweden found that 70% of intensive care patients studied were colonized with bacteria from other patients in the unit.<br/><br/>The researchers investigated the transmission of several strains of Staphylococcus bacteria, called CoNS. These strains are the primary cause of circulatory infections picked up in hospitals, and the third most common cause of all hospital infections. "These species have the ability to survive in the ICU surroundings on medical devices and equipment for weeks up to months," say the researchers. "They are specifically prone to causing catheter-related infections."<br/><br/>The team, led by Professor Charlotta Edlund, took swabs from the upper and lower airways of 20 intensive care patients that had required mechanical ventilation for at least three days. The researchers cultured the bacteria from these swabs and analysed the genetic fingerprints of Staphylococcus strains to identify bacteria that were identical or closely related. They could then assess the transmission rates of bacteria between patients, by seeing which patients harboured the same bacterial strains.<br/><br/>17 of the patients were colonised by CoNS during their hospital stay. In six of these cases, the bacteria had colonised the lower airways after the patient was ventilated, suggesting that the procedure itself had introduced the bacteria. 14 of the patients had either passed on a bacterial strain to another patient or received a bacterial strain from another patient. Worryingly, one patient passed on bacteria to a patient they had never met, having being discharged about three weeks prior to the other's arrival. This implies that the strain had survived in the ward during this period, perhaps on staff or on additional patients.<br/><br/>"Local guidelines for antibiotic use, close cooperation with infectious diseases specialists and restrictions with invasive treatment are strategies that can improve infection control and lower the incidence of hospital infections," write the authors. "Hand hygiene among hospital staff is [also] an important factor for preventing these infections."<br/><br/>The antibiotic resistance of the bacterial strains was analysed. 95% were resistant to penicillin, 86% to oxacillin, 48% to erythromycin, 42% to clindamycin, 54% to gentamicin, and 66% to ciprofloxacin. None were resistant to vancomycin, which is currently used to treat MRSA and other infections caused by other antibiotic-resistant bacteria.<br/><br/>Resistance to multiple antibiotics was commonly seen. 21% of the bacterial strains were resistant to six, 34% to at least five, and 59% to at least four of the tested antibiotics. "This multi-resistance will lead to higher consumption of broadspectrum antibiotics such as vancomycin, promoting the development of antibiotic resistance."<br/><br/>CoNS normally live on our skin without causing us any harm, but they can colonise airways or invasive devises (such as tubes used in mechanical ventilation), especially in people with weak immune systems. Although these bacteria do not always cause disease, colonisation is a risk factor for infection with other, more dangerous, antibiotic resistant bacterial strains. 13, 2011 — Expanded use of active surveillance for bacteria and of barrier precautions -- specifically, gloves and gowns -- did not reduce the transmission of two important antibiotic-resistant bacteria in ... full story<br/><br/>Feb. 24, 2011 — Infections are among the most frequent complications of a stay in hospital and raise the complication and mortality rates. New calculations have shown an incidence of almost 60,000 newly acquired | Il-pazjenti ta' kura intensiva huma speċjalment vulnerabbli għall-ġbir ta' infezzjonijiet fl-isptar, minħabba s-saħħa fqira tagħhom. Ir-riċerkaturi mill-Istitut Karolinska fl-Iżvezja sabu li 70 % tal-pazjenti tal-kura intensiva studjati kienu kkolonizzati b'batterji minn pazjenti oħra fl-unità.<br/><br/>Ir-riċerkaturi investigaw it-trażmissjoni ta' diversi razez ta' batterji Staphylococcus, imsejħa CNS. Dawn l-razez huma l-kawża primarja ta' infezzjonijiet ċirkolati miġbura fl-isptarijiet, u t-tielet l-aktar kawża komuni tal-infezzjonijiet tal-isptar kollha. "dawn l-ispeċijiet għandhom il-kapaċità li jgħixu fil-madwar ICU fuq apparat mediku u t-tagħmir għal ġimgħat sa xhur," jgħidu r-riċerkaturi. "Dawn l-ispeċijiet għandhom il-possibbiltà li jikkawżaw infezzjonijiet relatati mal-kateter."<br/><br/>It-tim, immexxi mill-Professur Charlotte Edlund, ħa l-iswaps mill-ajru ta' fuq u t'isfel ta' 20 pazjent ta' kura intensiva li kellhom bżonn ventilazzjoni mekkanika għal mill-inqas tlett ijiem. Ir-riċerkaturi kkultivaw il-batterja minn dawn l-iswaps u analizzaw il-marki tas-swaba' ġenetiċi ta' Staphylococcus strains biex jidentifikaw batterji li kienu identiċi jew relatati mill-qrib. Huma mbagħad jistgħu jivvalutaw ir-rati ta' trasmissjoni ta' batterji bejn il-pazjenti, billi jaraw liema pazjenti fixklu l-istess razez batteriċi.<br/><br/>17 mill-pazjenti kienu kkolonizzati mill-KONS matul iż-żjara tagħhom fl-isptar. Fis-sitt ta' dawn il-każijiet, il-batterja kienet ikkonsolidata l-passaġġi l-aktar baxxi wara li l-pazjent kien ivventilat, u b'hekk tissuġġerixxi li l-proċedura nnifisha kienet introduċiet il-batterja. 14 mill-pazjenti kienu għaddew jew għaddew minn pressjoni batterika lil pazjent ieħor jew rċevew pressjoni batterika minn pazjent ieħor. M'għandniex xi ngħidu, pazjent wieħed għadda minn batterji għal pazjent li qatt ma kien iltaqa', wara li ġie skarikat madwar tliet ġimgħat qabel il-wasla tal-ieħor. Dan jimplika li r-razza kienet baqgħet baqgħet ħajja matul dan il-perjodu, forsi fuq il-persunal jew fuq pazjenti addizzjonali.<br/><br/>Il-linji gwida lokali għall-użu antibijotiku, il-kooperazzjoni mill-qrib ma' speċjalisti tal-mard infettiv u restrizzjonijiet bi trattament invażiv huma strateġiji li jistgħu jtejbu l-kontroll tal-infezzjoni u jnaqqsu l-inċidenza tal-infezzjonijiet tal-isptar," jiktbu lill-awturi. L-iġjene tal-idejn fost il-persunal tal-isptar hija [ukoll] fattur importanti għall-prevenzjoni ta' dawn l-infezzjonijiet."<br/><br/>Ir-reżistenza għall-antibijotiċi tal-razez batteriċi ġiet analizzata. 95% kienu reżistenti għall-peniċillina, 86% għall-oxacillin, 48% għall-eritromiċina, 42% għall-klorin, 54% għall-ġenteamiċina, u 66% għall-ciprofloxacin. Ħadd ma kien reżistenti għall-vancomycin, li bħalissa huwa użat biex jittratta l-MSA u infezzjonijiet oħra kkawżati minn batterji oħra reżistenti għall-antibijotiċi.<br/><br/>Ir-reżistenza għal antibijotiċi multipli kienet tidher b'mod komuni. 21% tal-razez batteriċi kienu reżistenti għal sitta, 34% għal mill-inqas ħames, u 59% għal mill-inqas erba' mill-antibijotiċi ttestjati. "Din ir-reżistenza multipla se twassal għal konsum ogħla ta' antibijotiċi tal-ispettru bħall-vanomiċina, il-promozzjoni tal-iżvilupp ta' reżistenza għall-antibijotiċi."<br/><br/>Il-KONS normalment jgħixu fuq il-ġilda tagħna mingħajr ma jikkawżawna xi ħsara, iżda jistgħu jikkolonizza l-passaġġi ta' l-ajru jew id-derivattivi invażivi (bħal tubi użati fil-ventilazzjoni mekkanika), speċjalment f'persuni b'sistemi immuni dgħajfa. Għalkemm dawn il-batterja mhux dejjem jikkawżaw mard, il-kolonizzazzjoni hija fattur ta' riskju għall-infezzjoni ma' razez batteriċi oħra, aktar perikolużi, antibijotiċi reżistenti għall-antibijotiċi. 13, 2011 — Użu estiż ta' sorveljanza attiva għall-batterji u l-prekawzjonijiet tal-barriera - speċifikament, ingwanti u gowns - ma naqqasx it-trażmissjoni ta' żewġ batterji importanti reżistenti għall-antibijotiċi fi... storja sħiħa<br/><br/>Frar 24, 2011 — Infezzjonijiet huma fost l-aktar kumplikazzjonijiet frekwenti ta' żjara fl-isptar u jgħollu r-rati ta' kumplikazzjoni u mortalità. |
| Some Amish and Mennonites suffer rare genetic problems<br/><br/>Some Amish and Mennonite individuals struggle with genetic conditions little-seen in the general population. Certain Amish populations also exhibit diseases and conditions seen elsewhere, but at a higher rate than the general public. Amish and related groups have been assisted by outsiders in treating genetic problems.<br/><br/>What genetic diseases are common among Amish and Mennonites?<br/><br/>Amish and Mennonites exhibit certain rare diseases uncommon in other populations. These include Ellis-van Creveld syndrome (a type of dwarfism), glutaric aciduria, Crigler-Najjar syndrome, and maple syrup urine disease. Some illnesses are so uncommon that they are unique to these communities (such as Troyer Syndrome or Amish lethal microcephaly), or rarely seen elsewhere.<br/><br/>Some groups of Amish may exhibit diseases more likely to be seen in the general public, but at a higher rate. These include cystic fibrosis, muscular dystrophy and deafness in some communities.<br/><br/>Amish suffer genetic problems for a few reasons:<br/><br/>Small founding groups-individual Amish communities typically originate from relatively few families. Almost all of the Amish in Lancaster County, for example, originated from a few dozen 18th-century immigrant families.<br/><br/>Genetic isolation-converts to the Amish have been rare, and Amish only marry other Amish. This practice of endogamy, with few new bloodlines entering the population, has led to limited variation of genes.<br/><br/>Lancaster Amish descend from a small group of 18th-century immigrants<br/><br/>These two factors combine to create a "founder effect". A founder effect means that genetic variation is lost over time due to a limited number of founding individuals. Certain recessive traits found in a small founding population are amplified in future generations.<br/><br/>Additionally, most Amish tend to focus religious energies on their own sizeable families, as opposed to proselytizing others. These two factors make it unlikely for outsiders to join the Amish, a process by which the Amish genetic pool would otherwise be deepened over time.<br/><br/>Help for Amish and Mennonites with hereditary illnesses<br/><br/>Amish and outsiders sympathetic to their challenges have focused on early diagnosis and treatment of genetic illnesses in their communities. A number of institutions assist Amish and Mennonite families afflicted by inherited genetic disorders.<br/><br/>The Clinic for Special Children Benefit Auction is held annually in a number of places, including Leola in Lancaster County<br/><br/>The best-known is The Clinic for Special Children, located in Strasburg in Lancaster County. The Clinic, run by Dr. Holmes Morton, operates thanks to contributions, proceeds from annual benefit auctions taking place in Pennsylvania and Ohio, and by charging relatively small fees for services. The Clinic for Special Children also treats children from outside the Amish and Mennonite community and from around the world.<br/><br/>Other medical institutions, such as the Akron, Ohio Children's Hospital and the SUNY Upstate Medical University accommodate Amish and Mennonite patients, as in the case of cystic fibrosis treatment, for example.<br/><br/>Researchers fairly frequently enlist Amish help in conducting genetic studies, such as recent research on the presence of a "fat gene" in Amish individuals. Amish, increasingly aware of the benefits genetic research can bring to others and themselves, generally participate in large numbers.<br/><br/>Intermarriage across Amish society may be another solution to genetic issues, as Amish in different communities exhibit different bloodlines. However, differences in practice between Amish affiliations may prevent such intermarriage from occurring. Marriage between communities such as Lancaster County and Holmes County, Ohio, occur only rarely.<br/><br/>Enjoy this post? Subscribe by email to get updates from Amish America:<br/><br/>Related Articles to Do Amish have genetic disorders?<br/><br/>Genetic Treatment in the Plain Population You may be aware of the Clinic for Special Children in Strasburg, Pennsylvania, which treats children suffering from rare genetic illnesses, primarily within the Amish and Mennonite populations. The clinic…<br/><br/>Do we romanticize the Amish? When I first began spending time with the Amish, I felt like I was entering another world. I would drive my car from gritty Decatur, Illinois, where I was living…<br/><br/>Do Amish practice inbreeding? Today's question springs from a new study on a genetic mutation which causes a form of mental retardation among Amish. Like other genetic research involving the Amish, this study will probably…<br/><br/>Amish Tech Conference registration now open As mentioned before, this spring the Young Center for Anabaptist and Pietist Studies at Elizabethtown College will be hosting a 3-day conference entitled "Amish America: Plain Technology in a Cyber…<br/><br/>4 responses to Do Amish have genetic disorders?<br/><br/>I am doing a research paper on Amish genetic disorders and was wondering if there was more to the article listed above, or if you have nay more inforamtion regarding this topic. If you could contact me, I would appreciate it greatly. I can also be reached by phone at 302-690-4427. Thank you for your time.<br/><br/>In over 25 years living in an Amish community, I've witnessed a distressing and frightening array of genetic disorders among the children. Recently, however, I attended a presentation by a snake oil salesman who could have come straight out of a Gunsmoke episode. He insisted none of the maladies afflicting the children or others are genetic. He claimed they're all caused by dietary deficiencies. It was a throwback to the dark ages. If they bought his "nutrition supplements" then it would cure epilepsy, muscular dystrophy, downes syndrome and impotency, among others. He is misleading people and will injure them. Whats to be done with this fraud?<br/><br/>Has there been any effort toward education regarding the claims of the "snake oil" salesman? So many times people (or their families)who have been affected by a disorder that they cannot personally control are vulnerable to anything that comes along that feel gives some measure of managing the problem.<br/>Considering the practices of raising families inside a very small gene pool, it is a certainty that the incidence of these disorders will increase.<br/>Very sad.<br/><br/>Is there proof that these supplements wouldn't work? Perhaps not for some of these conditions, but other supplements have been well known to help aid a body to cure itself of a disease, such as cancer, Fibromyalgia (I hear a rising occurrence among the Amish), MS, Diabetes, etc. Remember that these supplements (if a good quality) may very well be those vitamins and minerals that we are lacking in modern diets, and the Amish diet in many places can be lacking, though I know many are as concerned about mainstream diets and their deficiencies. We have a doctor in Colorado who is primarily homeopathic but has his medical degree. He has a very high success rate using supplements and raw foods/juices to rid the body of cancer and other ailments, such as Fibromyalgia. And supplements and essential oils are all natural medicines given to us by God and largely overlooked by the population at large. Something that may appear to be "snake oil" to some, may very well be exactly what is needed. I don't know the individual persons, so I can't really comment on that. Recently, a purdue study showed that the fruit of the Soursop (graviola) tree killed cancer cells 10,000 times better than chemo drugs. Why is it not known? It could never be synthesized. They tried for seven years. | Xi Amish u Mennonite jsofru problemi ġenetiċi rari<br/><br/>Ċerti popolazzjonijiet ta' Amish u Menonite qed jitħabtu b'kundizzjonijiet ġenetiċi li ma jidhirx fil-popolazzjoni ġenerali. Ċerti popolazzjonijiet ta' Ammi juru wkoll mard u kundizzjonijiet li jidhru x'imkien ieħor, iżda b'rata ogħla mill-pubbliku ġenerali. Amish u gruppi relatati ġew assistiti minn barra fit-trattament ta' problemi ġenetiċi.<br/><br/>Liema mard ġenetiku huma komuni fost l-Ami u l-Mennonite?<br/><br/>Amish u Menonite juru ċertu mard rari mhux komuni f'popolazzjonijiet oħra. Dawn jinkludu s-sindrome ta' Ellis-van Creveled (tip ta' alfism), aċiduri gluċiċi, sindromu ta' crigler-Nipir, u mard ta' l-awrina tas-supple. Xi mard huwa tant komuni li huma uniċi għal dawn il-komunitajiet (bħalma huma s-Sindrome ta' Troyer jew il-mikrokreka letali Amish), jew rari li jidhru x'imkien ieħor.<br/><br/>Xi gruppi ta' Amish jistgħu juru mard aktar probabbli li jidher fil-pubbliku ġenerali, iżda b'rata ogħla. Dawn jinkludu fibrosis ċistika, distrofija muskolari u mard f'xi komunitajiet.<br/><br/>Amish tbati problemi ġenetiċi għal ftit raġunijiet:<br/><br/>Gruppi żgħar fundaturi ta' komunitajiet ta' Amish individwali tipikament joriġinaw minn familji relattivament ftit. Kważi kull wieħed mill-Amish fil-Kontea ta' Lancaster, pereżempju, oriġina minn ftit familji immigranti tas-seklu 18.<br/><br/>L-iżolament ġenetiku jmur lura għall-Amish kien rari, u Amish biss jiżżewġu oħra Amish. Din il-prattika ta' l-etgonomija, bi ftit demm ġodda li jidħlu fil-popolazzjoni, wasslet għal varjazzjoni limitata tal-ġeni.<br/><br/>Lancaster Amish densi minn grupp żgħir ta' immigranti tas-seklu 18<br/><br/>Dawn iż-żewġ fatturi jikkombinaw il-ħolqien ta' "effett ta' fundatur". Effett tal-fundatur jfisser li l-varjazzjoni ġenetika tintilef maż-żmien minħabba numru limitat ta' individwi fundaturi. Ċerti karatteristiċi riveduti li jinsabu f'popolazzjoni żgħira ta' fundatur huma amplifikati fil-ġenerazzjonijiet futuri.<br/><br/>Barra minn hekk, il-biċċa l-kbira ta' Amish għandu t-tendenza li jiffoka l-enerġiji reliġjużi fuq il-familji mdaqqsa tagħhom stess, għall-kuntrarju tal-prożamentizzazzjoni ta' oħrajn. Dawn iż-żewġ fatturi ma tantx jagħmluha probabbli li l-pajjiżi barranin jissieħbu fl-Ami, proċess li bih il-ġabra ġenetika Amish tkun tiddependi b'mod ieħor maż-żmien.<br/><br/>Għajnuna għal Amish u Mennonite b'mard ereditarju<br/><br/>Amish u barra minn pajjiżhom is-simpatetiku għall-isfidi tagħhom iffokaw fuq dijanjosi bikrija u trattament bikri ta' mard ġenetiku fil-komunitajiet tagħhom. Għadd ta' istituzzjonijiet jassistu lill-familji Ami u Mennonite milquta minn mard ġenetiku mxekkel.<br/><br/>Il-Klinika għall-Istkantazzjoni tal-Benefiċċji tat-Tfal tingħata kull sena f'għadd ta' postijiet, inkluż il-Leola fil-Kontea ta' Lancaster<br/><br/>L-aħjar magħrufa hija l-Klinika għat-Tfal Speċjali, li tinsab fi Strasburgu fil-Kontea ta' Lancaster. Il-Klinika, immexxija minn Dr. Holmes Morton, topera bis-saħħa ta' kontribuzzjonijiet, rikavati minn irkanti annwali ta' benefiċċju li jseħħu f'P Pennsylvania u Ohio, u billi tħallas miżati relattivament żgħar għas-servizzi. Il-Klinika għat-Tfal Speċjali tittratta wkoll lit-tfal minn barra l-Komunità Amish u Menonite u minn madwar id-dinja.<br/><br/>Istituzzjonijiet mediċi oħra, bħall-Akron, l-Isptar tat-Tfal ta' Ohio u l-Università Medika ta' l-Istati Uniti takkomoda Amish u Menonite pazjenti, bħal fil-każ ta' trattament ta' fibrosis ċikliku, per eżempju.<br/><br/>Ir-riċerkaturi b'mod ġust jelenkaw lil Amish għajnuna fit-twettiq ta' studji ġenetiċi, bħal riċerka reċenti dwar il-preżenza ta' "ġene tax-xaħam" fl-individwi ta' Amish. Amish, dejjem aktar konxju tal-benefiċċji tar-riċerka ġenetika tista' twassal għal oħrajn u huma stess, ġeneralment jipparteċipaw f'numri kbar.<br/><br/>Iż-żwieġ bejn is-soċjetà ta' Amish jista' jkun soluzzjoni oħra għal kwistjonijiet ġenetiċi, peress li Amish f'komunitajiet differenti juru bloodlines differenti. Madankollu, id-differenzi fil-prattika bejn l-affiljazzjonijiet ta' Amish jistgħu ma jħallux dan iż-żwieġ iseħħ. Iż-żwieġ bejn komunitajiet bħall-Kontea ta' Lancaster u l-Kontea ta' Holmes, Ohio, isseħħ biss rari.<br/><br/>Gawdi minn din il-kariga? Abbona bl-email biex tikseb aġġornamenti mill-Amerika ta' Amish:<br/><br/>L-Artikoli relatati ma' Do Amish għandhom mard ġenetiku?<br/><br/>Trattament ġenetiku fil-Popolazzjoni Sempliċi Inti tista' tkun taf bil-Klinika għat-Tfal Speċjali fi Strasburgu, Pennsylvania, li tittratta lit-tfal li jsofru minn mard ġenetiku rari, primarjament fil-popolazzjonijiet Amish u Menonite.<br/><br/>Meta bdejt nqatta' l-ħin mal-Amish, kont qed noħroġ f'dinja oħra.Nista' ssuq il-karozza tiegħi min-nejta Dekatur, Illinois, fejn kont qed ngħix...<br/><br/>X'inhu r-rebbiegħa tal-lum minn studju ġdid dwar mutazzjoni ġenetika li tikkawża forma ta' ritardazzjoni mentali fost l-Amish. Bħal riċerka ġenetika oħra li tinvolvi l-Amix, dan l-istudju x'aktarx se...<br/><br/>Ir-reġistrazzjoni tal-Konferenza b'potenzal Issa miftuħa Kif imsemmi qabel, dan ir-rebbiegħa iċ-Ċentru Żgħażagħ għall-Istudji Anabattist u Pietist fil-Kulleġġ ta' Eliżabetta se tkun qed torganizza konferenza ta' 3 ijiem bl-isem ta' l-Amerika: Apple Technology f'Cyber...<br/><br/>4 tweġibiet għal Do Amish għandhom diżordnijiet ġenetiċi?<br/><br/>Qed nagħmel dokument ta' riċerka dwar id-disturbi ġenetiċi ta' Amish u kont qed nistaqsi jekk kienx hemm aktar fl-artiklu elenkat hawn fuq, jew jekk għandek xi aktar informazzjoni dwar dan is-suġġett. Kapaċi wkoll jintlaħaq bit-telefon fuq 302-690-4427. Grazzi għall-ħin tiegħek.<br/><br/>F'aktar minn 25 sena jgħixu f'komunità Amish, kont xhud ta' firxa ta' problemi ġenetiċi fost it-tfal. Madankollu, attendejt preżentazzjoni minn bejjiegħ taż-żejt tas-sriep li seta' joħroġ minn episodju ta' Gun smoke. Hu insista li ħadd mill-arma li kien qed jolqot it-tfal jew oħrajn ma kien ġenetiku. Huwa qal li kollha huma kkawżati minn nuqqasijiet ta' dieta.Huwa a throwback għall-etajiet skur., Jekk huma mixtrija tiegħu "supplimenti tan-nutrizzjoni" imbagħad kien kura epilessija, id-distrophy muskolari, downs syndrome u impotency, fost oħrajn. Hu jqarraq bin-nies u jweġġa'hom. X'għandu jsir b'dan il-frodi?<br/><br/>Kien hemm xi sforz lejn l-edukazzjoni dwar it-talbiet ta'"sriep taż-żejt" bejjiegħ? Għalhekk ħafna drabi n-nies (jew il-familji tagħhom) li ġew affettwati minn disturb li ma jistgħux personalment jikkontrollaw huma vulnerabbli għal xi ħaġa li tiġi matul dik is-sentiment tagħti xi miżura ta' ġestjoni tal-problema.<br/>Meta wieħed iqis il-prattiki taż-żieda tal-familji f'grupp ta' ġeni żgħar ħafna, huwa ċertezza li l-inċidenza ta' dawn id-disturbi se tiżdied.<br/>Żarbun ħafna.<br/><br/>Hemm prova li dawn is-supplimenti mhux se jaħdmu? Forsi mhux għal xi wħud minn dawn il-kundizzjonijiet, iżda supplimenti oħra kienu magħrufa sew biex jgħinu għajnuna korp biex jikkuraw lilu nnifsu ta' marda, bħall-kanċer, Fibromyalgia (qed nisma' okkorrenza dejjem tikber fost l-Amish), MS, dijabete, eċċ. Ftakar li dawn is-supplimenti (jekk kwalità tajba) jistgħu ħafna jkunu dawk il-vitamini u minerali li aħna ma jonqsux f'diet moderni, u d-dieta Amishi f'ħafna postijiet jistgħu jkunu nieqsa, għalkemm naf ħafna huma kkonċernati dwar dieti mainstream u n-nuqqasijiet tagħhom. Għandna tabib fil Colorado li huwa primarjament omeopatiċi iżda għandu tiegħu grad mediku.Għandu rata ta' suċċess għolja ħafna bl-użu ta' supplimenti u ikel/juices mhux maħduma biex isuqu l-korp tal-kanċer u ailments oħra, bħal Fibromyalgia. U s-supplimenti u żjut essenzjali huma kollha mediċini naturali mogħtija lilna minn Alla u l-aktar injorati mill-popolazzjoni kbira. Xi ħaġa li jistgħu jidhru li tkun "żejt velenu tas-sriep" xi wħud, jistgħu jkunu tajjeb ħafna eżattament dak li hu meħtieġ. Ma nafx lill-persuni individwali, allura ma nistax verament nikkummenta dwar dan. Riċentement, studju pur wera li l-frott tas-Sourop (graviola) siġra qatel kanċer ċelloli 10,000 darba aħjar minn drogi Chemo. Għaliex mhix magħrufa? Qatt ma seta' jiġi sintetizzat. Huma ppruvaw għal seba' snin. |
| Which political party in the United States has claimed to represent the interests of the working class and the disadvantaged since the early 1900s?<br/>A. the Democratic Party<br/>B. the Libertarian Party<br/>C. the Progressive Party<br/>D. the Republican Party<br/><br/>A. the Democratic Party is political party in the United States that has claimed to represent the interests of the working class and the disadvantaged since the early 1900s | Liema partit politiku fl-Istati Uniti talab li jirrappreżenta l-interessi tal-klassi tax-xogħol u tal-iżvantaġġ mill-bidu tas-snin 1900?<br/>A. il-Parti demokratika<br/>B. il-Partit Nazzjonalista<br/>C. il-Parti Progressiva<br/>D. il-Parti r-Repubblika<br/><br/>A. il-Partit Demokratiku huwa partit politiku fl-Istati Uniti li stqarret li jirrappreżenta l-interessi tal-klassi tax-xogħol u tal-iżvantaġġ mill-bidu tas-snin disgħin |
| It's not functioning like a normal shuffle does. it processes through the songs, but does not catch a song after the shuffle starts. Also, if I press a song to play without shuffle, it flashes the song, then goes back to the playlist.<br/><br/>The same songs on my macbook and ipad work fine, both under shuffle and next-advance mode.<br/><br/>My iPhone 5 has the exact same problem (and it's only about one month old). In shuffle mode, with the "shake to shuffle" off and just the "x" selected, if I try to skip ahead one song, it skips three or four songs and then just stops randomly at whichever song it wants to. This needs to be fixed. Very annoying | M'huwiex qed jiffunzjona bħal xaft normali ma jgħaddix mill-kanzunetti, iżda ma jaqbadx kanzunetta wara li jibda l-suffle. Ukoll, jekk I agħfas kanzunetta biex tilgħab mingħajr xaft, huwa beraq il-kanzunetta, imbagħad tmur lura għall-playlist.<br/><br/>L-istess kanzunetti fuq tiegħi Macbook u l-ipad multa xogħol, kemm taħt shuffle u l-mod li jmiss.<br/><br/>iPhone tiegħi 5 għandha l-istess problema (u huwa biss madwar xahar). Fil-modalità ta' l-suffle, ma' l-"hake biex tifflejk" u eżatt l-"x" magħżula, jekk I jippruvaw taqbeż qabel kanzunetta waħda, huwa taqbeż tliet kanzunetti jew erba u mbagħad sempliċement twaqqaf b'mod każwali kull kanzunetti li jixtieq li. Dan jeħtieġ li jiġu ffissati. |
